# Post-GWAS Analysis

## I. Cancer

* **2022 Cancer Discovery** - Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles Somatic Mutations and 3D Genomic Architecture

## II. Immune Diseases

* ✅ \[review] **2023 Nature Reviews Nephrology** - Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants
* **2019 Nature Communications** - SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell speciﬁc enhancer that controls disease-critical microRNA expression

### RNA editing

* ✅ [**2022 Nature**](https://pubmed.ncbi.nlm.nih.gov/35922514/) - RNA editing underlies genetic risk of common inflammatory diseases
* **2020 Genome Biology** - Human A-to-I RNA editing SNP loci are enriched in GWAS signals for autoimmune diseases and under balancing selection

### RNA modification

* **2022 Nature Genetics** - Genetic drivers of m6A methylation in human brain, lung, heart and muscle

